Literature DB >> 1531675

Identification of two biologically distinct strains of transmissible mink encephalopathy in hamsters.

R A Bessen1, R F Marsh.   

Abstract

Experimental transmission of the Stetsonville, Wisconsin, U.S.A. source of transmissible mink encephalopathy (TME) to outbred Syrian golden hamsters resulted in two distinct syndromes, termed hyper (HY) and drowsy (DY), that diverge by the third hamster passage. The syndromes differed with respect to clinical signs, incubation period, brain titre, brain lesion profile and pathogenicity in mink. HY hamster TME had an incubation period of 65 +/- 1 days and was characterized by clinical signs of hyperaesthesia and cerebellar ataxia. Lethargy and the absence of hyperexcitability or cerebellar ataxia were representative of DY hamster TME which had an incubation period of 168 +/- 2 days. At endstage, HY and DY infected animals had brain titres of 10(9.5) LD50/g and 10(7.4) LD50/g of tissue, respectively, indicating that the replication kinetics of these two strains is different. Hamster TME passaged back into mink revealed that only DY retained mink pathogenicity. This suggests that the DY agent is the major mink pathogen in the Stetsonville TME source that is also pathogenic in hamsters after a long incubation period. The HY agent is likely to be a minor component of the original TME mink brain that replicates more rapidly than DY agent in hamsters, but alone is non-pathogenic in mink. The presence of the HY and DY strains of agent that retain their biological characteristics on repeated hamster passage in the Stetsonville TME source requires that the informational molecule encoding these transmissible agents has the capacity to account for this biological diversity.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1531675     DOI: 10.1099/0022-1317-73-2-329

Source DB:  PubMed          Journal:  J Gen Virol        ISSN: 0022-1317            Impact factor:   3.891


  123 in total

1.  Strains of [PSI(+)] are distinguished by their efficiencies of prion-mediated conformational conversion.

Authors:  S M Uptain; G J Sawicki; B Caughey; S Lindquist
Journal:  EMBO J       Date:  2001-11-15       Impact factor: 11.598

2.  Rapid prion neuroinvasion following tongue infection.

Authors:  Jason C Bartz; Anthony E Kincaid; Richard A Bessen
Journal:  J Virol       Date:  2003-01       Impact factor: 5.103

3.  Strain-specified relative conformational stability of the scrapie prion protein.

Authors:  D Peretz; M R Scott; D Groth; R A Williamson; D R Burton; F E Cohen; S B Prusiner
Journal:  Protein Sci       Date:  2001-04       Impact factor: 6.725

4.  Accelerated shedding of prions following damage to the olfactory epithelium.

Authors:  Richard A Bessen; Jason M Wilham; Diana Lowe; Christopher P Watschke; Harold Shearin; Scott Martinka; Byron Caughey; James A Wiley
Journal:  J Virol       Date:  2011-11-30       Impact factor: 5.103

5.  In vitro generation of high-titer prions.

Authors:  Ronald A Shikiya; Jason C Bartz
Journal:  J Virol       Date:  2011-09-28       Impact factor: 5.103

6.  Conformational transformation and selection of synthetic prion strains.

Authors:  Sina Ghaemmaghami; Joel C Watts; Hoang-Oanh Nguyen; Shigenari Hayashi; Stephen J DeArmond; Stanley B Prusiner
Journal:  J Mol Biol       Date:  2011-08-04       Impact factor: 5.469

Review 7.  Heterogeneous seeding of HET-s(218-289) and the mutability of prion structures.

Authors:  William Wan; Gerald Stubbs
Journal:  Prion       Date:  2014-02-18       Impact factor: 3.931

8.  Disease-associated prion protein in neural and lymphoid tissues of mink (Mustela vison) inoculated with transmissible mink encephalopathy.

Authors:  D A Schneider; R D Harrington; D Zhuang; H Yan; T C Truscott; R P Dassanayake; K I O'Rourke
Journal:  J Comp Pathol       Date:  2012-05-16       Impact factor: 1.311

9.  Prion formation, but not clearance, is supported by protein misfolding cyclic amplification.

Authors:  Ronald A Shikiya; Thomas E Eckland; Alan J Young; Jason C Bartz
Journal:  Prion       Date:  2014       Impact factor: 3.931

10.  Prion interference is due to a reduction in strain-specific PrPSc levels.

Authors:  Jason C Bartz; Michelle L Kramer; Meghan H Sheehan; Jessica A L Hutter; Jacob I Ayers; Richard A Bessen; Anthony E Kincaid
Journal:  J Virol       Date:  2006-11-01       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.